MAPT and dementia: First of all, the ratio of Aβ1–42/P-tau181P was shown to have a significantly higher diagnostic power than Aβ1–42, T-tau, and the Aβ1–42/T-tau ratio, while P-tau181P was found to perform significantly better than T-tau to discriminate between AD and non-AD dementia.